Neoadjuvantdurvalumabwithorwithoutstereotacticbodyradiotherapyinpatientswithearly-stagenon-small-celllungcancer:asingle-centre,randomisedphase2trialcIAP1/2antagonismeliminatesMHCclassI-negativetumorsthroughTcell-dependentreprogrammingofmononuclearphagocytesMIFisa3’flapnucleasethatfacilitatesDNAreplicationandpromotestumorgrowthNeutralizationofPD-L2isEssentialforOver